The Lipoprotein(a) Education and Research Forum (Lp(a) Forum) is a globally recognized, independent, and non-profit initiative dedicated to advancing knowledge in the field of lipoprotein(a) science and therapeutics. The Forum provides clinicians and researchers with open access to peer-reviewed educational resources that highlight Lp(a) as a significant risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis, even in individuals with low LDL cholesterol levels.

Supported by leading companies such as Amgen and Novartis, the Lp(a) Forum aggregates expertise from various scientific and clinical stakeholders. It offers insightful summaries, reviews, and recorded presentations related to the latest advancements in Lp(a) therapeutics. The Forum also encourages dialogue about future research directions to improve patient care. Through its multimedia educational resources, the Lp(a) Forum aims to enhance the understanding of Lp(a) and support healthcare professionals in optimizing patient outcomes. This initiative is essential for fostering awareness and addressing gaps in knowledge within the medical and research community.